Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Immunology

Just One Shot

| Stephanie Sutton

A vaccine using mRNA demonstrates potential for broad influenza protection.

Disease Area Analytical science

Real-Time Tumor Analysis

| William Aryitey

MALDI and a SpiderMass device could save valuable surgery time

Disease Area Diagnostics & prognostics

Markers for Prognostic Progress

| Ana Robles

Better lung cancer treatment through biomarkers

Disease Area Drug discovery

Go Forth and Find a Flu Vaccine

| Kjetil Ree

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Disease Area Drug discovery

Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Disease Area Diagnostics & prognostics

Cost-effective Cancer Checks

| William Aryitey

Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods

Disease Area Diagnostics & prognostics

Variant Database Collaborations – for Cancer and Beyond

| Obi Griffith and Heidi Rehm

It's important to research relevant academic papers, but it's equally important to make sure it's still relevant

Disease Area Cancer

Anticipating NRAS Resistance

| William Aryitey

How researchers are unraveling the mystery of melanoma drug resistance

Disease Area Pain & critical care

Hurt Blocker

| James Strachan

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions

Disease Area Diagnostics & prognostics

Super Saliva Test

| William Aryitey

Can an oral fluid assay for HIV be as sensitive as a blood test?

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register